newsfilter
← Latest News
Business Wire·

Aptinyx Announces Formation of Scientific Advisory Board

Leading experts in neuroscience will provide guidance to support the advancement of Aptinyx's novel NMDA receptor modulation platform and pipeline Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therap